Clinical Trial Update: Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles. [Phase 4]

View source ↗

Summary

Phase 4 trial examining the effects of 5 weeks of dapagliflozin on skeletal muscle insulin sensitivity in adults with type 2 diabetes; results posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skeletal Muscle Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2, Skeletal Muscle Insulin Sensitivity | Phase 4 | Status: COMPLETED | Results posted: 2021-01-15